These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 8861994)

  • 21. Impact of the U.S. panel on cost-effectiveness in health and medicine.
    Phillips KA; Chen JL
    Am J Prev Med; 2002 Feb; 22(2):98-105. PubMed ID: 11818178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty years of cost-effectiveness analysis in medical imaging: are we improving?
    Otero HJ; Rybicki FJ; Greenberg D; Neumann PJ
    Radiology; 2008 Dec; 249(3):917-25. PubMed ID: 19011188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What Are the Strength of Recommendations and Methodologic Reporting in Health Economic Studies in Orthopaedic Surgery?
    Makhni EC; Steinhaus ME; Swart E; Bozic KJ
    Clin Orthop Relat Res; 2015 Oct; 473(10):3289-96. PubMed ID: 26024580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to develop cost-conscious guidelines.
    Eccles M; Mason J
    Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth and quality of the cost-utility literature, 1976-2001.
    Neumann PJ; Greenberg D; Olchanski NV; Stone PW; Rosen AB
    Value Health; 2005; 8(1):3-9. PubMed ID: 15841889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness Analysis Appraisal and Application: An Emergency Medicine Perspective.
    April MD; Murray BP
    Acad Emerg Med; 2017 Jun; 24(6):754-768. PubMed ID: 28295894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine.
    Siegel JE; Torrance GW; Russell LB; Luce BR; Weinstein MC; Gold MR
    Pharmacoeconomics; 1997 Feb; 11(2):159-68. PubMed ID: 10172935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force report--Part VI.
    Shi L; Hodges M; Drummond M; Ahn J; Li SC; Hu S; Augustovski F; Hay JW; Smeeding J
    Value Health; 2010; 13(1):28-33. PubMed ID: 19883403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis in the nursing literature, 1992-1996.
    Allred CA; Arford PH; Mauldin PD; Goodwin LK
    Image J Nurs Sch; 1998; 30(3):235-42. PubMed ID: 9753838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inconsistencies in the "societal perspective" on costs of the Panel on Cost-Effectiveness in Health and Medicine.
    Meltzer D; Johannesson M
    Med Decis Making; 1999; 19(4):371-7. PubMed ID: 10520672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of abstracts of papers reporting original cost-effectiveness analyses.
    Rosen AB; Greenberg D; Stone PW; Olchanski NV; Neumann PJ
    Med Decis Making; 2005; 25(4):424-8. PubMed ID: 16061894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis and emergency medical services for children: issues and applications.
    Tilford JM
    Ambul Pediatr; 2002; 2(4 Suppl):330-6. PubMed ID: 12135408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporating adherence in cost-effectiveness analyses of asthma: a systematic review.
    Chongmelaxme B; Chaiyakunapruk N; Dilokthornsakul P
    J Med Econ; 2019 Jun; 22(6):554-566. PubMed ID: 30663455
    [No Abstract]   [Full Text] [Related]  

  • 38. When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature.
    Talmor D; Shapiro N; Greenberg D; Stone PW; Neumann PJ
    Crit Care Med; 2006 Nov; 34(11):2738-47. PubMed ID: 16957636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A primer on cost-effectiveness in the allergy clinic.
    Shaker M; Greenhawt M
    Ann Allergy Asthma Immunol; 2019 Aug; 123(2):120-128.e1. PubMed ID: 31128234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in average costs among federally sponsored state-organized cancer detection programs: economies of scale?
    Mansley EC; Duñet DO; May DS; Chattopadhyay SK; McKenna MT
    Med Decis Making; 2002; 22(5 Suppl):S67-79. PubMed ID: 12369233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.